Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Review Best Secured Card No Annual Fee options to find the best-value cards that help you build credit without annual charges.
14,293 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Can Bitcoin surge to $100,000 by the end of 2026? This article breaks down the forces that could push BTC higher, the...
Tally, a leading DAO governance tool used by hundreds of communities, will shut down after five years as regulators c...
As millions of Baby Boomers retire, a fundamental shift is underway for markets and investment strategies. This story...
Investors are weighing bets on critical metals as supply chains shift and demand from EVs and renewables climbs. This...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
A cultural meme is shaping money decisions in licensing, estate planning, and brand strategy. Here’s how chuck norris...
Software shares have slid toward what some call bargain territory, but a growing argument centers on whether hidden c...
A fresh study highlights a widening split among high earners. The k-shaped economy left many six-figure earners on th...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...